Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
111C-acetate[1] Acetate---[2] 86, 88 💬
22D and 3D trans-thoracic echocardiography----[2] 86, 88 💬
3[18F]Fluoro-2-deoxy-2-D-glucose[1] D-glucose[1] Glucose 💬 --[2] 86, 88 💬
4[ACT-293987]----[1] 88 💬
5[JNJ-67896062 / ACT-064992]----[2] 86, 88 💬
6[JNJ-67896062/ ACT-064992]----[2] 86, 88 💬
7Acetate[1] Acetate---[52] 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
8ACT-064992----[5] 51, 85, 86, 88, 210 💬
9ACT-293987----[3] 51, 86, 88 💬
10Adempas----[5] 51, 86, 88, 225, 299 💬
11Adempas (Riociguat, BAY63-2521)[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 86, 88 💬
12Adempas®----[2] 86, 88 💬
13Ambrisentan[1] Ambrisentan[1] Ambrisentan 💬 [1] EDNRA 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[10] 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬
14Ambrisentan 5 mg[1] Ambrisentan[1] Ambrisentan 💬 [1] EDNRA 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 88 💬
15Ammonia[1] Ammonia[1] Ammonia solution, strong 💬 --[6] 6, 17, 86, 88, 251, 296 💬
16Atorvastatin[1] Atorvastatin[2] Atorvastatin calcium ,
Atorvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
17Ballon Pulmonary Angioplasty----[1] 88 💬
18Balloon pulmonary angioplasty----[1] 88 💬
19Balloon Pulmonary Angioplasty (BPA)----[1] 88 💬
20BARNASCAN----[1] 88 💬
21BAY 63-2521----[2] 86, 88 💬
22BAY 63-2521 coated tablets 0.5 mg----[2] 86, 88 💬
23BAY 63-2521 coated tablets 1 mg----[2] 86, 88 💬
24BAY 63-2521 coated tablets 1.5 mg----[2] 86, 88 💬
25BAY 63-2521 coated tablets 2 mg----[2] 86, 88 💬
26BAY 63-2521 coated tablets 2.5 mg----[2] 86, 88 💬
27BAY 63-2521 IR coated tablet 1.0 mg----[1] 88 💬
28BAY 63-2521 IR coated tablet 1.5 mg----[1] 88 💬
29BAY 63-2521 IR coated tablet 2.0 mg----[1] 88 💬
30BAY 63-2521 IR coated tablet 2.5 mg----[1] 88 💬
31BAY 63-2521 IR tablet 0.5 mg----[1] 88 💬
32BAY 63-2521 IR tablet 1.0 mg----[1] 88 💬
33BAY 63-2521 IR tablet 1.5 mg----[1] 88 💬
34BAY 63-2521 IR tablet 2.0 mg----[1] 88 💬
35BAY 63-2521 IR tablet 2.5 mg----[1] 88 💬
36BAY 63-2521 tablets 0.5 mg----[2] 86, 88 💬
37BAY 63-2521 tablets 1 mg----[2] 86, 88 💬
38BAY 63-2521 tablets 1.5 mg----[2] 86, 88 💬
39BAY 63-2521 tablets 2 mg----[2] 86, 88 💬
40BAY 63-2521 tablets 2.5 mg----[2] 86, 88 💬
41BAY1237592----[2] 86, 88 💬
42Behavioral: respiratory and exercise therapy----[1] 88 💬
43Behavioral: respiratory and exercise therapy with supplemental oxygen[1] Oxygen[1] Oxygen 💬 --[1] 88 💬
44Blood sample----[33] 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
45Bosentan[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
46BOSENTAN MONOHYDRATE[1] Bosentan[2] Bosentan ,
Bosentan 💬 		[2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 51, 84, 86, 88 💬
47Catheter directed therapy----[1] 88 💬
48Cysteine[1] Cysteine[2] L-Cysteine ,
Cysteine hydrochloride 💬 		--[13] 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
49D-glucose[1] D-glucose[1] Glucose 💬 --[3] 49, 86, 88 💬
50Dapagliflozin[1] Dapagliflozin[1] Dapagliflozin 💬 --[16] 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
51Dapagliflozin 10 MG [Farxiga][1] Dapagliflozin[1] Dapagliflozin 💬 --[2] 86, 88 💬
52Diagnostic Test: Endogenous thrombin potential[1] Thrombin[1] Thrombin 💬 --[2] 86, 88 💬
53Diagnostic Test: Light transmission aggregometry----[2] 86, 88 💬
54Diagnostic Test: Platelet function analyzer-100----[2] 86, 88 💬
55Diagnostic Test: Rotational thromboelastometry----[2] 86, 88 💬
56Diltiazem[1] Diltiazem[3] Diltiazem hydrochloride ,
Diltiazem malate ,
Diltiazem 💬 		[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 51, 58, 86, 88 💬
57Discontinuation of riociguat[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 88 💬
58Edoxaban[1] Edoxaban[3] Edoxaban tosilate hydrate ,
Edoxaban ,
Edoxaban tosylate 💬 		[1] F10 💬 [1] Complement and coagulation cascades 💬[4] 46, 71, 88, 222 💬
59Fludeoxyglucose[1] Fludeoxyglucose[1] Fludeoxyglucose F 18 💬 --[3] 34, 84, 88 💬
60Forxiga----[4] 86, 88, 222, 223 💬
61Forxiga (dapagliflozin)[1] Dapagliflozin[1] Dapagliflozin 💬 --[2] 86, 88 💬
62Genetic: Saliva sample----[2] 86, 88 💬
63Gold[1] Gold---[71] 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
64GSK1325760----[2] 86, 88 💬
65Hyperpolarized Xe129----[5] 51, 85, 86, 88, 299 💬
66Imatinib[1] Imatinib[2] Imatinib mesylate ,
Imatinib 💬 		[3] ABL1,
KIT,
PDGFRA 💬 		[34] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
67IMATINIB MESILATE[1] Imatinib[2] Imatinib mesylate ,
Imatinib 💬 		[3] ABL1,
KIT,
PDGFRA 💬 		[34] Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[3] 13, 86, 88 💬
68Iodine[1] Iodine[1] Iodine 💬 --[5] 28, 46, 88, 96, 118 💬
69JNJ-67896062 / ACT-064992----[2] 86, 88 💬
70Long term oxygen therapy[1] Oxygen[1] Oxygen 💬 --[1] 88 💬
71Macitentan[1] Macitentan[1] Macitentan 💬 [2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[5] 51, 85, 86, 88, 210 💬
72Macitentan 10 mg[1] Macitentan[1] Macitentan 💬 [2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 51, 86, 88 💬
73Macitentan 10mg[1] Macitentan[1] Macitentan 💬 [2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 51, 88 💬
74MACITENTAN COMPRESSE[1] Macitentan[1] Macitentan 💬 [2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 86, 88 💬
75MACITENTAN TABLETS[1] Macitentan[1] Macitentan 💬 [2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 86, 88 💬
76Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb----[2] 86, 88 💬
77Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth----[2] 86, 88 💬
78MK-4836----[2] 86, 88 💬
79MultiHance----[2] 86, 88 💬
80N-acetyl Cysteine[1] Cysteine[2] L-Cysteine ,
Cysteine hydrochloride 💬 		--[6] 13, 34, 85, 88, 296, 310 💬
81Nitric Oxide[1] Nitric Oxide[1] Nitric oxide 💬 --[12] 46, 51, 85, 86, 88, 97, 98, 210, 251, 294, 299, 340 💬
82Opsumit----[2] 86, 88 💬
83Opsumit®----[3] 86, 88, 210 💬
84Opsumit®Product Name: Macitentan tablets Product Code: JNJ-67896062 / ACT-064992Pharmaceutical Form: Film-coated tabletINN or Proposed INN: MACITENTANCAS Number: 441798-33-0Current Sponsor code: JNJ-67896062-AAAOther descriptive name: ACT-064992Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: Macitentan tabletsProduct Code: JNJ-67896062 / ACT-064992Pharmaceutical Form: Film-coated tabletINN or Proposed INN: MACITENTANCAS Number: 441798-33-0Current Sponsor code: JNJ-67896062-AAAOther descriptive name: ACT-064992Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: Macitentan tabletsProduct Code: JNJ-67896062 / ACT-064992Pharmaceutical Form: Film-coated tabletINN or Proposed INN: MACITENTANCAS Number: 441798-33-0Current Sponsor code: JNJ-67896062-AAAOther descriptive name: ACT-064992Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 37.5-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use[1] Macitentan[1] Macitentan 💬 [2] EDNRA,
EDNRB 💬 		[9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 86, 88 💬
85Other: 6-minute walk distance (6MWD) test----[2] 86, 88 💬
86Other: 6-minute walk distance (6MWD) test on ambient air----[2] 86, 88 💬
87Other: 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
88Other: 6-minute walk distance test with supplemental oxygen[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
89Other: Blood draw----[17] 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
90Other: Blood Samples----[13] 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
91Other: Health surveys----[2] 86, 88 💬
92Other: Oxygen Administration[1] Oxygen[1] Oxygen 💬 --[1] 88 💬
93Other: Sham Oxygen therapy[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
94Other: Supplemental oxygen therapy[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
95Oxygen[1] Oxygen[1] Oxygen 💬 --[30] 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
96Oxygen, liquid[1] Oxygen[1] Oxygen 💬 --[2] 86, 88 💬
97Potassium[1] Potassium[1] Potassium 💬 --[17] 36, 46, 57, 58, 66, 67, 88, 93, 94, 97, 98, 115, 167, 179, 215, 223, 235 💬
98Pulmonary endarterectomy----[1] 88 💬
99Pulmonary Endarteriectomy----[1] 88 💬
100Pulmonary hypertension (PH)-specific medication----[1] 88 💬
101Pulmonary hypertension-specific therapy----[1] 88 💬
102Radiation: Cardiac PET imaging using F-18-FDG, N-13 ammonia( NH3)[1] Ammonia[1] Ammonia solution, strong 💬 --[1] 88 💬
103Radiation: Computed tomography lung subtraction iodine mapping[1] Iodine[1] Iodine 💬 --[1] 88 💬
104Radiation: magnetic resonance imaging----[2] 86, 88 💬
105Remodulin (R)----[1] 88 💬
106Remodulin 10mg/ml 20ml----[1] 88 💬
107Remodulin 1mg/ml 20ml----[1] 88 💬
108Remodulin 2.5mg/ml 20ml----[1] 88 💬
109Remodulin 5mg/ml 20ml----[1] 88 💬
110RIOCIGUAT[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[6] 51, 84, 86, 88, 225, 299 💬
111Riociguat (Adempas)[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 88 💬
112Riociguat (Adempas, BAY63-2521)[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[4] 51, 86, 88, 299 💬
113Riociguat Oral Tablet[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[3] 51, 86, 88 💬
114RITUXIMAB[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[54] 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
115Ro 47-0203----[4] 51, 85, 86, 88 💬
116Routine Treatment----[1] 88 💬
117Sauerstoff----[2] 86, 88 💬
118Selexipag[1] Selexipag[1] Selexipag 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[6] 47, 51, 70, 84, 86, 88 💬
119Supplemental oxygen via a mask[1] Oxygen[1] Oxygen 💬 --[1] 88 💬
120Systemic anticoagulation----[1] 88 💬
121Thrombin[1] Thrombin[1] Thrombin 💬 --[3] 86, 88, 97 💬
122Tracleer----[8] 13, 51, 84, 85, 86, 88, 210, 211 💬
123TRACLEER 125MG 56CPR RIV.----[1] 88 💬
124TRACLEER*56CPR RIV 125MG----[3] 51, 86, 88 💬
125Treprostinil[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[6] 51, 84, 85, 86, 88, 210 💬
126TREPROSTINIL SODIUM[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[3] 51, 86, 88 💬
127Uptravi----[3] 84, 86, 88 💬
128Volibris----[4] 51, 85, 86, 88 💬
129Warfarin[1] Warfarin[3] Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		[2] NQO1,
VKORC1 💬 		[5] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[15] 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
130Warfarin Potassium[2] Potassium,
Warfarin		[4] Warfarin sodium ,
Warfarin potassium ,
Potassium ,
Warfarin 💬 		[2] NQO1,
VKORC1 💬 		[5] Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬[1] 88 💬